AMY HART,ASHOK V. PURANDARE,GRETCHEN SCHROEDER,HONGHE WAN,JAMES W. GREBINSKI,JENNIFER INGHRIM
申请号：
BR112012004970
公开号：
BR112012004970A2
申请日:
2010.09.02
申请国别(地区):
BR
年份:
2016
代理人:
摘要：
The present invention provides compounds of formula I and pharmaceutically acceptable salts thereof. The formula I compounds inhibit tyrosine kinase activity of JAK2, thereby making them useful as antiproliferative agents for the treatment of cancer and other diseases.
